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SUMMARY. The object of the present study was to investigate the anticancer properties of total alkaloids
from Solanum lyratum Thunb (SLT-A), including the inhibitory effect of SLT-A on HeLa cells and the
apoptosis-inducing capacity in vitro. In our study, cytotoxicity was measured by the growth inhibition as-
say and detection of apoptosis was performed by Hoechst33324 and Tdt-mediated dUTP nick end labeling
(TUNEL) staining assays. The in vitro cytotoxic studies were complemented by the cell cycle analysis and
determination caspase-3 activity. Reverse transcription-polymerase chain reaction (RT-PCR) assay was
applied on the expression of apoptosis-associated genes. The result showed that treatment of HeLa cells
with SLT-A resulted in the growth inhibition effect, and the IC50 value was approximately 82 μg/ml. SLT-
A (80 μg/ml) induced more cell apoptosis of HeLa cells and accumulated the cells in the G2/M phase com-
pared with the control cells. On the other hand, the expression of p53 and Bax gene was increased in the
cells treated with SLT-A (80 μg/ml), with an increase in the activity of caspase-3, while Bcl-2 expression
was not changed compared to the control cells. Our results demonstrated that SLT-A presented antiprolif-
erative activity in HeLa cells and might be a potential anticancer drug.
